Navellier & Associates Inc. Takes Position in Biogen Inc. (NASDAQ:BIIB)

Navellier & Associates Inc. bought a new stake in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,164 shares of the biotechnology company’s stock, valued at approximately $556,000. Other institutional investors have […]

Related Keywords

United States ,Germany ,Priya Singhal ,Raymond James ,Vanguard Group Inc ,Securities Exchange Commission ,Navellier Associates Inc ,Geode Capital Management ,Nasdaq ,Blackrock Inc ,Biogen Inc ,Needham Company ,Pricet Rowe Associates Inc ,Free Report ,Street Corp ,Capital Management ,Pricet Rowe Associates ,Trading Down ,Get Free Report ,Visit Holdingschannel ,Biogen Daily ,Biogen ,Nasdaq Biib ,Biib ,Medical ,09062x10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,